Arteris, Inc. (AIP) Company Overview

US | Technology | Semiconductors | NASDAQ

What does Arteris do?

4B+
production systems-on-chip shipped with Arteris technology
Company disclosure through FY2025.
299
employees
Company headcount at December 31, 2025.
261
issued and pending patent assets
Combined issued and pending portfolio at FY2025 year-end.

Arteris, Inc. is a Nasdaq-listed semiconductor intellectual-property and software company trading under the ticker AIP. It does not fabricate chips. Instead, it supplies the “system IP” that helps chip designers connect processors, memory blocks, accelerators, interfaces, and security functions inside a system-on-chip. Its network-on-chip technology replaces increasingly unwieldy bundles of point-to-point wires with an engineered on-chip communications fabric. The result can be faster design closure, lower power use, less wiring congestion, and more predictable performance in complex silicon.

What problem does its system IP solve?

Modern chips combine many specialized compute engines, and the difficulty is no longer only designing each block. The blocks must exchange data at high speed without creating bottlenecks, excessive power draw, or verification risk. Arteris automates much of that interconnect architecture. Its software also helps assemble register maps and integrate third-party IP, while the Cycuity acquisition added hardware-security assurance. The 2025 Form 10-K describes a product set spanning non-coherent and coherent interconnects, SoC integration, and security analysis.

Identity factor Arteris position Why it matters
Core industry Semiconductor IP and electronic design automation software Economics resemble a high-gross-margin licensing business rather than a capital-intensive chip manufacturer.
Primary customers Semiconductor companies, systems companies, and design teams building advanced SoCs A design win can become embedded for the life of the customer’s chip program.
Geographic reach Americas, Asia-Pacific, Europe, and the Middle East Diversification is useful, but China and export-control exposure remain material.
Strategic role Data movement, integration, and security inside complex silicon Arteris benefits when chip complexity grows faster than internal engineering teams can manage it.

Why does a relatively small supplier matter?

Arteris occupies a high-leverage point in the semiconductor value chain. Its IP may be a small part of development cost, yet an interconnect failure can delay the whole chip. Customers therefore pay for proven architecture, tools, and support that reduce schedule risk. Heterogeneous computing, AI accelerators, automotive electronics, and chiplets all intensify that need.

How does Arteris make money?

Arteris combines term-based licenses, support and maintenance, production royalties, and professional services. Licensing creates high-margin access to the technology; royalties extend a successful design win after the customer’s chip reaches volume production; services help with deployment and adaptation.

84.0% of Q1 2026 revenue came from licensing, support, and maintenance, calculated from $19.3M of that revenue on $22.9M of total revenue.

Which revenue stream is largest?

Revenue mix by stream — Q1 2026
Licensing, support, maintenance $19.3M
Variable royalties $2.5M
Services and other $1.2M
Licensing remains the economic core. Services expanded after Cycuity added government-contract work. Period: quarter ended March 31, 2026.
Revenue layer How it is earned Economic character Research implication
License revenue Rights to use IP and software, generally recognized over the contractual term High gross margin, but timing depends on deal structure and delivery obligations Annual contract value and remaining performance obligations can lead reported revenue.
Support and maintenance Updates, technical support, and continued access Relationship-based and more recurring than one-time project work Renewal quality helps indicate whether customers remain committed to the toolchain.
Variable royalties Per-unit or usage-linked payments after customer chips enter production Delayed but potentially long-lived and scalable Royalty growth is evidence that older design wins are progressing into commercial volume.
Professional services Deployment, customization, training, and contract engineering Lower-margin and more labor-dependent than licensing Useful for adoption, but a rising mix can temporarily reduce consolidated gross margin.

Why does revenue lag design activity?

1. Design win
A customer selects Arteris after a technical and commercial evaluation.
2. Chip development
The customer integrates and verifies the IP during a program that can last one to three years.
3. Production ramp
Royalties often begin one to five years after design completion, depending on the product cycle.
4. Royalty tail
A successful chip may generate royalties for seven years or longer.

Reported revenue reflects past contracts, while design starts, annual contract value, remaining performance obligations, and royalties describe different pipeline stages. One weak measure does not automatically signal weaker demand, and a strong design-win period may still take years to become production revenue.

Which products and end markets matter most?

Non-coherent interconnect
FlexNoC, FlexWay, and FlexGen connect heterogeneous blocks where full cache coherence is unnecessary. This is the broadest part of the product family.
Coherent interconnect
Ncore supports cache-coherent architectures used in high-performance computing and advanced processors.
SoC integration
Magillem Connectivity, Magillem Registers, and CSRCompiler automate integration and register-management work.
Hardware security
Cycuity Radix products test whether security controls behave as intended in complex hardware designs.

How does the portfolio fit together?

The products form one workflow: interconnect IP moves data, integration software organizes blocks and registers, interface IP improves memory access, and Cycuity tests hardware security. This breadth supports cross-selling and deeper customer integration. The official FlexNoC product page highlights configurability, quality of service, power management, and functional-safety options relevant to automotive and other mission-critical designs.

Market Demand driver Arteris relevance Key constraint
AI and high-performance computing More accelerators, memory traffic, and chiplet links FlexGen and Ncore target complex, bandwidth-intensive architectures. Large customers may build internal interconnect technology.
Automotive Software-defined vehicles, safety, and centralized compute Functional-safety capabilities and long product lives can support durable royalties. Qualification cycles are long and vehicle production can be cyclical.
Aerospace and defense Secure and reliable custom silicon Security assurance and integration tools expand the addressable workflow. Government contracting creates compliance and execution complexity.
Communications, consumer, and industrial Specialized edge processing and connectivity Broad configurability supports many SoC architectures. Demand is fragmented and exposed to end-market cycles.

Where was revenue generated?

Revenue by customer billing geography — FY2025
FY2025
Asia-Pacific — 47.6%
Americas — 41.5%
Europe and Middle East — 10.9%
Asia-Pacific was the largest billing geography in FY2025. Geographic billing is not necessarily the same as the ultimate location of chip use.

The mix provides global reach but creates policy sensitivity. China and the broader Asian semiconductor cycle materially affect results, making export controls and trade restrictions direct operating risks. Geographic diversity nevertheless reduces dependence on one domestic market.

What does Arteris's latest quarter show?

$22.9M
Q1 2026 revenue
39%
year-over-year revenue growth
$84.9M
annual contract value at March 31, 2026
$118.3M
remaining performance obligations at March 31, 2026

The quarter ended March 31, 2026 showed strong top-line expansion but continued GAAP losses. Revenue rose because licensing activity was healthy, royalty revenue grew, and Cycuity contributed services. The official Q1 2026 earnings release also reported 25 confirmed design starts, reinforcing the view that customer activity remained active beyond recognized revenue.

Which figures changed the financial picture?

Metric Q1 2026 Interpretation
Revenue $22.9M Growth was broad enough to lift all three disclosed revenue categories.
Gross profit $19.7M The business remained high margin despite acquisition-related services costs.
GAAP operating loss $9.3M loss Operating expenses still exceeded gross profit, so scale has not yet produced GAAP profitability.
GAAP net loss $8.0M loss Equivalent to a $0.17 diluted loss per share for the period.
Operating cash flow $7.1M outflow Quarterly cash conversion was negative, contrasting with positive FY2025 cash generation.
Cash and investments $41.9M Includes cash equivalents plus short- and long-term investments at March 31, 2026.

Why did gross margin decline?

85.8%
GAAP gross margin — Q1 2026
Green arc equals gross profit divided by revenue. The margin remained high, but it was lower than the prior-year quarter because acquired services carried subcontractor costs.

Revenue and forward contract metrics are growing, but Arteris still invests ahead of current gross profit. The core question is whether licensing and royalties can eventually outgrow research, sales, and administrative spending after acquisition-related cost noise subsides.

Which turning points shaped Arteris's strategy?

Arteris evolved from an interconnect specialist into a broader system-design platform. Each major product or acquisition expanded the problem it could solve, while also increasing execution demands.

  1. 2003–2004
    Arteris was founded and incorporated, establishing an early focus on network-on-chip architecture before SoC complexity became mainstream.
  2. 2011
    FlexNoC and FlexWay began shipping, creating the commercial base for the company’s non-coherent interconnect franchise.
  3. 2016
    The initial Ncore release extended Arteris into cache-coherent designs, important for high-performance processors and accelerators.
  4. 2020
    The Magillem acquisition added SoC integration and register-management software, broadening the workflow around the interconnect.
  5. 2021–2022
    Arteris completed its public listing and then acquired Semifore, adding CSRCompiler and increasing its software footprint.
  6. 2025
    FlexGen launched as an AI-assisted interconnect generator aimed at increasingly large and complex chip designs.
  7. 2026
    The Cycuity acquisition added hardware-security assurance, moving Arteris further into verification and trusted-silicon workflows.

What did these moves change?

Earlier model
Interconnect first
The core proposition was a better way to move data among blocks inside an SoC.
Current direction
System IP platform
Integration software, coherent fabrics, interfaces, and security increase wallet share and workflow relevance.

Portfolio expansion improves cross-selling but requires integration, sales coordination, and continued investment. Cycuity added security capability alongside goodwill, contingent consideration, and lower-margin services. The FlexGen launch represents the organic strategy: automate interconnect generation so Arteris can address larger designs without proportional manual effort.

What gives Arteris a competitive advantage?

Arteris's moat is not a consumer brand; it is the accumulated proof that its IP can work inside costly, schedule-sensitive chip programs where failure is unacceptable.

Why are switching costs and barriers meaningful?

Customer-built interconnect is Arteris's most important substitute. Internal development consumes scarce architects and verification engineers and must be maintained across product generations. After Arteris becomes part of a design method, switching can require re-architecture, re-verification, retraining, and renewed safety or security work—especially costly in long-lived automotive, industrial, and communications programs.

Embedded switching costs Strong
Technical specialization Strong
Scale versus major EDA vendors Limited
Royalty installed base Developing

Who are the main competitors and substitutes?

Competitive force Relative position Pressure on Arteris Arteris response
Customer-built interconnect The most direct substitute Large chip teams may prefer control and avoid external royalties. Offer faster deployment, proven quality, support, and lower schedule risk.
Arm interconnect technology A named third-party competitor in company filings Arm can bundle technology into a broad processor and system-IP ecosystem. Maintain architectural neutrality across processor, memory, foundry, and IP ecosystems.
Smaller specialist vendors Focused alternatives in selected niches Price competition or targeted technical features can challenge individual deals. Use installed experience, patent assets, global support, and portfolio breadth.
Broader EDA and IP ecosystems Partners in some workflows and potential strategic encroachers Larger vendors have deeper distribution and acquisition capacity. Integrate broadly and remain the specialist system-IP layer rather than a closed stack.

A new entrant needs years to build a product, customer trust, and a royalty base. Competition is therefore shaped by credibility and engineering history, not price alone. The moat is strongest when Arteris becomes part of a reusable customer platform and weakest in one-off designs that internal teams or bundled alternatives can serve.

How financially strong is Arteris?

Arteris combines software-like gross margins with substantial operating losses. Its revenue base remains small relative to global engineering, sales, public-company, and stock-compensation costs. Financial strength therefore depends on liquidity and a credible path to operating leverage.

What does the annual baseline show?

FY2025 revenue
$70.6M
Up 22% year over year.
FY2025 gross margin
90.2%
A strong licensing margin before operating expenses.
FY2025 operating loss
$33.1M
Research and commercial investment remained well above gross profit.
FY2025 free cash flow
$5.3M
Operating cash flow less capital expenditure was positive.
Financial driver FY2025 Q1 2026 signal Analytical reading
Research and development $49.9M Still the largest operating expense category R&D protects technical relevance but delays GAAP profitability.
Operating cash flow $6.7M inflow $7.1M outflow Contract billing and working-capital timing make quarterly cash flow uneven.
Capital expenditure $1.4M Low relative to revenue The model is not factory-intensive; people and acquired technology are the main reinvestment needs.

How should liquidity and deferred revenue be interpreted?

At March 31, 2026, cash and investments totaled about $41.9M. The balance sheet also carried substantial deferred revenue, which represents future software, support, or service obligations rather than bank debt requiring dollar-for-dollar repayment. That distinction matters when interpreting thin reported equity.

The Q1 2026 Form 10-Q records Cycuity at an estimated $43.1M purchase value using cash, stock, and contingent consideration. The deal adds integration and dilution risk. A disciplined outcome requires cross-selling and product leverage, not merely incremental services revenue.

Who owns AIP stock, and why does governance matter?

Voting structure
1 share, 1 vote
Arteris has a single common-stock class rather than a dual-class structure.
CEO beneficial ownership
20.0%
K. Charles Janac, including shares and exercisable options reported in the 2026 proxy.

Who has economic and voting influence?

Holder or group Reported stake Source period Why it matters
K. Charles Janac 20.0% beneficial ownership 2026 proxy The long-serving CEO and chair has material alignment and substantial influence over strategic decisions.
Bayview Legacy LLC 19.8% April 9, 2026 record-date context Bayview is controlled by Janac, so its stake is part of the same influence rather than an independent block.
Needham Investment Management 7.2% Latest ownership filing cited in the proxy A meaningful outside institutional holder can increase scrutiny of execution and capital allocation.
Directors and executive officers as a group 23.3% 2026 proxy Insiders collectively have enough ownership to influence outcomes, though not unilateral majority control.

The 2026 proxy statement shows one-share-one-vote economics, yet Janac’s stake, chair role, and long tenure still create concentrated leadership influence without a dual-class structure.

How is the board structured?

Board independence
A clear majority of directors were identified as independent, supporting formal oversight.
Combined CEO and chair
Janac holds both roles, concentrating agenda-setting despite a lead independent director.
Classified board
Staggered director classes can promote continuity but make rapid board change more difficult.
Capital-allocation signal
Governance is primarily judged through reinvestment, acquisitions, and dilution during the company’s expansion phase.

The governance question is whether concentrated leadership enables patient technical investment or limits challenge around losses, equity issuance, and acquisitions. Insider ownership creates alignment but reduces the practical influence of smaller holders. Board independence and Cycuity integration are useful tests of oversight quality.

AI chiplets, automotive, and security define the growth opportunity

Arteris's growth case depends on rising chip complexity. AI accelerators require internal bandwidth, chiplets multiply die-to-die links, software-defined vehicles consolidate functions, and security moves earlier into hardware design. Each trend increases the value of reusable, verified system IP.

Which growth paths are most concrete?

AI and chiplet platforms
AMD licensed FlexGen for next-generation AI chiplet designs, an important reference for large, complex architectures.
Reusable subsystem design
The IC-Link by imec collaboration places Arteris NoC IP in reference subsystems for AI and high-performance ASICs.
Hardware security assurance
Arm expanded use of Cycuity Radix across additional CPU programs, validating the acquired technology with a major ecosystem participant.
Automotive platform reuse
Long product lives, safety requirements, and centralized compute can turn a successful design into a durable royalty stream.

The July 2026 Arm security-assurance expansion is notable because Arm also competes in interconnects. Semiconductor relationships are layered: companies can compete in one area and collaborate in another. Arteris benefits when customers prefer interoperable technology across processors, foundries, interfaces, and design tools.

What risks and valuation drivers matter most?

AIP does not fit a simple software-multiple analysis. Results combine ratable license recognition, delayed royalties, acquisition effects, stock compensation, and uneven contract cash flows. Pipeline conversion, cost discipline, customer choices, and geopolitical access therefore drive the risk profile.

Which risks could weaken the story?

Design wins may not become royalties
Customer programs can be delayed, canceled, redesigned, or ship at lower volume than expected.
Internal alternatives and bundling
Large customers can build their own fabric, while broader vendors can bundle interconnect with other IP.
China and export controls
China represented 23.8% of Q1 2026 revenue, making licensing restrictions and trade policy financially relevant.
Customer concentration
One customer represented 13% of FY2025 revenue, so individual renewal or program decisions can move results.
Persistent GAAP losses
High R&D and commercial spending must eventually convert into operating leverage, not only non-GAAP improvement.
Acquisition and dilution risk
Cycuity added goodwill, contingent consideration, issued shares, and integration obligations.
Key-license dependency
The Qualcomm-related FlexNoC development-environment license contains change-of-control and assignment considerations.
Leadership transition
The planned CFO retirement in 2026 adds execution sensitivity during acquisition integration and a profitability transition.

Which metrics belong in a DCF or operating model?

Annual contract value Remaining performance obligations Confirmed design starts Variable royalty growth GAAP gross margin R&D intensity Free cash flow Share-count dilution
Revenue growth
Model license expansion separately from the slower, more scalable royalty ramp.
Margin normalization
Estimate whether services mix and acquisition costs recede while licensing remains dominant.
Operating leverage
Test how quickly gross profit can outgrow research, sales, administration, and stock compensation.
Cash conversion
Normalize billings and working-capital timing rather than annualizing one quarter’s cash flow.
Terminal risk
Use conservative assumptions because technology shifts, internal substitution, and customer concentration can impair long-duration royalties.

A favorable valuation case requires rising contract metrics, a larger royalty contribution, gross-margin recovery, and operating expenses growing slower than gross profit. The downside is failed scale economics: continued equity issuance and investment without durable GAAP or cash profitability. The company’s annual risk discussion belongs beside any forecast because long royalty lags magnify forecasting errors.

What is the key takeaway from Arteris analysis?

Arteris supplies infrastructure for semiconductor complexity. Its technology helps developers move data, integrate reusable IP, and verify security without building every capability internally. Billions of production SoCs, patent depth, customer relationships, and expanding AI, chiplet, automotive, and security use cases support its technical relevance.

The financial story is less mature. High gross margins and growing contract metrics coexist with large GAAP losses, uneven cash flow, and Cycuity integration risk. Shareholders receive one vote per share, but the CEO-chair’s substantial stake and tenure give management meaningful influence over reinvestment and acquisitions.

Integrated research conclusion
Arteris matters because interconnect, integration, and hardware security are becoming bottlenecks in advanced chip design. Rising complexity, switching costs, royalty potential, and ecosystem validation support the story. It weakens if design starts fail to become production royalties, customers internalize technology, export limits restrict markets, or expenses and dilution outrun gross-profit growth. Monitor ACV, RPO, design starts, royalty growth, gross-margin recovery, GAAP operating leverage, free cash flow, and Cycuity integration.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(AIP) Arteris, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5